retatrutide clinical trial phase Lilly's triple agonist, retatrutide, successful in two additional 3 obesity trials, delivering significant improvements in weight and A1C Today, we shared new data
Pay in 4 interest-free payments of $6.59 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23






















